Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
| 10.39 BATS BZX Real-Time Price As of 9:50am ET |  -0.065 / -0.62%Today’s Change | 6.07 Today|||52-Week Range 20.21 | +5.97% Year-to-Date |
Latest TEVA News | Press Releases
| Why Long-Term Investors Should Avoid TEVA Stock Like the Plague Jan 22 / MotleyFool.com - Paid Partner Content | California Governor Gavin Newsom Proposes State-Run Prescription Drug Label Jan 09 / MotleyFool.com - Paid Partner Content |
| The Top 3 Contrarian Stocks to Buy in 2020 Jan 13 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 10.45 |
| Today’s open | 10.36 |
| Day’s range | 10.25 - 10.40 |
| Volume | 595,001 |
| Average volume (3 months) | 18,428,649 |
| Market cap | $11.3B |
Data as of 9:50am ET, 01/23/2020
Growth & Valuation
| Earnings growth (last year) | +85.71% |
| Earnings growth (this year) | -18.38% |
| Earnings growth (next 5 years) | +1.70% |
| Revenue growth (last year) | -16.69% |
| P/E ratio | NM |
| Price/Sales | 0.84 |
| Price/Book | 0.77 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BGNEBeigene Ltd | -1.75 | -1.03% |
| BBIOBridgeBio Pharma Inc | -0.14 | -0.41% |
| AKRXAkorn Inc | +0.03 | +2.26% |
Data as of 9:51am ET, 01/23/2020
Financials
| Next reporting date | February 7, 2020 |
| EPS forecast (this quarter) | $0.61 |
| Annual revenue (last year) | $18.8B |
| Annual profit (last year) | -$2.1B |
| Net profit margin | -11.40% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Generic |
No executives to display |
Corporate headquarters Petach Tikva, Hamerkaz |
Forecasts
